TNDM — TANDEM DIABETES CARE INC
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1438133 ·
Last close
$16.60
Market Cap
$1.14B
52W High
$26.38
52W Low
$12.26
ADV30
3,006,613
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 247,221,000 | 136,788,000 | -17,434,000 | -20,393,000 | 1,153,394,000 | 179,325,000 | 1,020,991,000 |
| Dec 2025 | 290,383,000 | 167,460,000 | 8,294,000 | -589,000 | 881,112,000 | 90,634,000 | 725,942,000 |
| Sep 2025 | 249,253,000 | 134,292,000 | -22,863,000 | -21,165,000 | 874,653,000 | 91,947,000 | 741,688,000 |
| Jun 2025 | 240,678,000 | 125,855,000 | -31,859,000 | -52,400,000 | 875,736,000 | 64,112,000 | 742,453,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$19,611,000
Investing CF
$-131,758,000
Financing CF
$235,482,000
CapEx
$-58,375,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.40
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,272,928,000
Inventory
$126,400,000
Receivables
$140,672,000
ST Investments
$390,931,000
EBIT TTM
$-91,615,000
Pretax Income TTM
$-98,060,000
Interest Exp TTM
$6,445,000
Analysts
21
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,027,534,976
EBITDA
$-43,203,000
Free Cash Flow
$-20,262,376
Enterprise Value
$1,302,061,824
Total Cash
$570,256,000
Total Debt
$734,734,976
Shares Out
68,529,089
Trailing EPS
$-1.37
Book Value
$1.93
ROE
-65.7%
ROA
-3.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,014,736,000 | -167,306,000 | -204,710,000 | 881,112,000 | 725,942,000 | — | -9,721,000 |
| Dec 2024 | 940,203,000 | -99,127,000 | -96,025,000 | 967,658,000 | 704,560,000 | — | 24,225,000 |
| Dec 2023 | 747,718,000 | -233,230,000 | -222,611,000 | 952,658,000 | 639,026,000 | — | -31,810,000 |
| Dec 2022 | 801,217,000 | -92,848,000 | -94,594,000 | 1,052,785,000 | 612,838,000 | — | 50,464,000 |
TTM Snapshot
Revenues TTM
$813,767,000
NetIncome TTM
$-99,388,000
OpCashFlow TTM
$0
Assets (Latest)
$967,658,000
Forward EPS
$0.06
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AVNS | AVANOS MEDICAL, INC. | $1.17B | $24.96 | — |
| IRMD | IRADIMED CORP | $1.20B | $93.60 | — |
| KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | $1.22B | $20.85 | — |
| INSP | Inspire Medical Systems, Inc. | $1.23B | $42.70 | — |
| CNMD | CONMED Corp | $1.05B | $34.77 | — |
News headlines (Yahoo Finance, 1h cache)
NeuroPace (NPCE) Down 0.6% Since Last Earnings Report: Can It Rebound?
2026-06-11 15:30 · Yahoo
How The Investment Story For Tandem Diabetes Care (TNDM) Is Evolving Without New Analyst Targets
2026-06-07 23:07 · Yahoo
Wall Street Analysts See a 56.2% Upside in Tandem Diabetes Care (TNDM): Can the Stock Really Move This High?
2026-06-05 13:55 · Yahoo
Tandem Diabetes Care Automated Insulin Delivery Systems Receive CE Mark for Type 2 Diabetes and Type 1 Diabetes During Pregnancy
2026-06-05 12:30 · Yahoo
Zacks.com featured highlights include Tandem, Dell and CNO Financial
2026-06-05 08:50 · Yahoo
Reasons to Add Tandem Diabetes Stock to Your Portfolio Right Now
2026-06-04 15:56 · Yahoo
3 Stocks to Invest in as Broker Rating Upgrades Signal Upside
2026-06-04 13:30 · Yahoo
Tandem Diabetes Valuation: Is 1.1x Sales a Buy?
2026-06-03 15:25 · Yahoo
Wells Fargo Upgrade Highlights Tandem Diabetes Care Pharmacy And Pump Shift
2026-06-03 09:09 · Yahoo
TNDM Stock: What to Know About Tandem's 2026 Reset
2026-06-02 14:56 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.